GGrantIndex
Sort

64,565 grants matching drug discovery

Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer

$589,881
Carol Ann Lange · University Of Minnesota · R01 · FY2022 · CA

Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer

$589,881
Carol Ann Lange · University Of Minnesota · R01 · FY2023 · CA

DREAM Complex Maintenance of Human Beta Cell Quiescence

$589,802
Andrew F. Stewart · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK

Development of novel selective Rac inhibitors for refractory leukemias

$589,782
David A Williams · Boston Children'S Hospital · R01 · FY2019 · CA

Small Animal CT Image Guided Xray Irradiation System

$589,750
Cheng-Shie Wuu · Columbia University Health Sciences · S10 · FY2012 · OD

Novel tools for in vitro electrophysiology and neurotrauma modeling

$589,718
John D Finan · University Of Illinois At Chicago · R01 · FY2024 · NS

Proton pumping and energy metabolism of the ring stage malaria parasites

$589,706
Hangjun Ke · Drexel University · R01 · FY2024 · AI

Ultrasound System for Transational Research

$589,686
Albert J Sinusas · Yale University · S10 · FY2021 · OD

Rational Development of Anti-Trypanosoma Cruzi Drugs

$589,661
Frederick Simmons Buckner · University Of Washington · R01 · FY2009 · AI

Sourcing Bioactive Secondary Metabolites from Great Lakes Fungi

$589,594
Robert Henry Cichewicz · University Of Oklahoma · R01 · FY2014 · GM

Computational modulator design and machine learning to target protein-protein interactions

$589,588
Yingkai Zhang · New York University · R35 · FY2025 · GM

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$589,574
David S Stephens · Emory University · UM1 · FY2022 · AI

NOVEL L-NUCLEOSIDE COMBINATION ANTI-HBV THERAPY

$589,490
Idenix Pharmaceuticals · R44 · FY2001 · AI

Neuropharmacology of Tramadol: Clinical Efficacy and Abuse Potential

$589,457
William Walton Stoops · University Of Kentucky · R01 · FY2010 · DA

Vaccina Virus DNA Topoisomerase

$589,448
Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2010 · GM

Development of a Low Cost High Performance Animal PET

$589,293
Wai-Hoi Wong · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · EB

HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression

$589,282
Raymond T Chung · Massachusetts General Hospital · R01 · FY2016 · DK

Vasculitis and Translational Medicine

$589,258
Peter Grayson · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR

IDBR: Collaborative Research: Real time secretion: single cell analyzer

$589,208
James A Glazier · Indiana University · · FY2012 · BIO

Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers

$589,183
Remi Adelaiye-Ogala · State University Of New York At Buffalo · R37 · FY2023 · CA

Gene Regulation in the Opioid Dependent Human Brain (Project 2)

$589,113
Peter Christopher Scacheri · Research Triangle Institute · P50 · FY2022 · DA

Discovering compounds with robust pro-longevity activities

$589,100
Gordon J. Lithgow · Buck Institute For Research On Aging · U01 · FY2013 · AG

Discovery of Hsp100-selective inhibitors for targeting multiple microbial pathogens

$589,070
Michal Zolkiewski · Kansas State University · R01 · FY2020 · AI

Screening for a Drug for Sickle Cell Disease

$589,047
William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential

$589,007
Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2007 · AI